C. Niu

发表

Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis.

Xi C. He, K. Akashi, Jie Chen, 2003, Blood.

Identification of the haematopoietic stem cell niche and control of the niche size

Haiyang Huang, Ling Ye, Xi C. He, 2003, Nature.

Low-dose ionizing radiation induces direct activation of natural killer cells and provides a novel approach for adoptive cellular immunotherapy.

C. Niu, Wei Li, Haofan Jin, 2014, Cancer biotherapy & radiopharmaceuticals.

Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.

C. Niu, N. Wong, P. Johnson, 1999, Cancer genetics and cytogenetics.

Epigenetic suppression of the antitumor cytotoxicity of NK cells by histone deacetylase inhibitor valproic acid.

C. Niu, Ji-fan Hu, Wei Li, 2016, American journal of cancer research.

Distinct biological effects of low-dose radiation on normal and cancerous human lung cells are mediated by ATM signaling

C. Niu, Ji-fan Hu, Wei Li, 2016, Oncotarget.

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

C. Niu, T. Naoe, S. Waxman, 1997, Blood.

Trans-repressive effect of NUP98-PMX1 on PMX1-regulated c-FOS gene through recruitment of histone deacetylase 1 by FG repeats.

C. Niu, Saijuan Chen, Zhu Chen, 2006, Cancer research.

Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer

C. Niu, Hua He, Wei Li, 2015, Journal of Translational Medicine.

Combined cellular immunotherapy and chemotherapy improves clinical outcome in patients with gastric carcinoma.

C. Niu, Yizhuo Wang, C. Yao, 2015, Cytotherapy.

Molecular cytogenetic characterization and clinical relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemia

C. Niu, Yong-mei Zhu, Saijuan Chen, 2001, Leukemia.

Loss of Imprinting Control of the lncRNA H19-fetal Mitogen IGF2 Gene Cluster in the Decidual Microenvironment of Patients With Idiopathic Spontaneous Miscarriages

C. Niu, A. Hoffman, Ji-fan Hu, 2021, SSRN Electronic Journal.

Prognostic value of MICA/B in cancers: a systematic review and meta-analysis

C. Niu, J. Cui, Yijing Zhao, 2017, Oncotarget.

Two cases of AML (M2) with a t(8;19)(q22;q13): a new cytogenetic variant.

C. Niu, P. Li, D. Lu, 2000, Cancer genetics and cytogenetics.

Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients.

S J Chen, C. Niu, Jiong Hu, 1999, Blood.

Gamma-delta (γδ) T cells: friend or foe in cancer development?

C. Niu, J. Cui, Yijing Zhao, 2018, Journal of Translational Medicine.

Gamma-delta (γδ) T cells: friend or foe in cancer development?

C. Niu, J. Cui, Yijing Zhao, 2018, Journal of Translational Medicine.

Rbm15 Modulates Notch-Induced Transcriptional Activation and Affects Myeloid Differentiation

C. Niu, S. Morris, A. Chi, 2007, Molecular and Cellular Biology.

Feasibility and clinical significance of real-time quantitative RT-PCR assay of PML-RARalpha fusion transcript in patients with acute promyelocytic leukemia.

C. Niu, Jiong Hu, Zhi-xiang Shen, 2001, The hematology journal : the official journal of the European Haematology Association.

Nerves in the Tumor Microenvironment: Origin and Effects

C. Niu, Ji-fan Hu, Wenjun Wang, 2020, Frontiers in Cell and Developmental Biology.

Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma

C. Niu, Wei Li, Dongsheng Xu, 2016, Oncotarget.

Transcriptional Accessibility for Multi-Tissue and Multi-Hematopoietic Lineage Genes is Hierarchically Controlled During Early Hematopoiesis

Jie Chen, Xi C. He, K. Akashi, 2002 .

Validating the pivotal role of the immune system in low‐dose radiation‐induced tumor inhibition in Lewis lung cancer‐bearing mice

C. Niu, Hui Li, J. Cui, 2018, Cancer medicine.

Profiling the epigenetic interplay of lncRNA RUNXOR and oncogenic RUNX1 in breast cancer cells by gene in situ cis-activation.

C. Niu, A. Hoffman, Ji-fan Hu, 2019, American journal of cancer research.

Detection of chromosome over- and underrepresentations in hyperdiploid acute lymphoblastic leukemia by comparative genomic hybridization.

C. Niu, N. Wong, P. Johnson, 1998, Cancer genetics and cytogenetics.

Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells.

C. Niu, Dan Li, J. Cui, 2013, Asian Pacific journal of cancer prevention : APJCP.

Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application

C. Niu, Wei Li, L. Bai, 2017, Journal of Translational Medicine.

Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage

C. Niu, J. Chen, W. Wu, 2001, Leukemia.

Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer

C. Niu, Wei Li, Haofan Jin, 2015, Journal of Translational Medicine.

Gene expression in CD34(+) cells from normal bone marrow and leukemic origins.

C. Niu, S. Ren, G. Fu, 2000, The hematology journal : the official journal of the European Haematology Association.

In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells

C. Niu, Ji-fan Hu, Hua He, 2015, BMC Immunology.

Transcriptional divergence between cDC1s and cDC2s: an AP1–IRF composite element-dependent program

C. Niu, Shan Zhu, Jingtao Chen, 2021, Cellular & Molecular Immunology.

Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression‐free survival for patients with hepatocellular carcinoma

C. Niu, Hua He, Wei Li, 2014, International journal of cancer.

Adoptive transfer of natural killer cells in combination with chemotherapy improves outcomes of patients with locally advanced colon carcinoma.

C. Niu, Yizhuo Wang, C. Yao, 2018, Cytotherapy.

High yield and purification of recombinant human apolipoprotein E3 in Pichia pastoris.

C. Niu, Man-man Su, Tianmin Xu, 2009, Protein expression and purification.

c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.

C. Niu, Jiwang Zhang, M. Tang, 2009, Blood.

c-Myc is a target of RNA-binding motif protein 15 in the regulation of adult hematopoietic stem cell and megakaryocyte development.

C. Niu, Jiwang Zhang, P. Breslin, 2009, Blood.

PD-1-positive Natural Killer Cells have a weaker antitumor function than that of PD-1-negative Natural Killer Cells in Lung Cancer

C. Niu, Wei Li, Dongsheng Xu, 2020, International journal of medical sciences.

Non-Coated Rituximab Induces Highly Cytotoxic Natural Killer Cells From Peripheral Blood Mononuclear Cells via Autologous B Cells

C. Niu, Wei Li, Dongsheng Xu, 2021, Frontiers in Immunology.

Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cells.

C. Niu, Wei Li, Dongsheng Xu, 2018, Oncology letters.

Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients

C. Niu, Ji-fan Hu, Hua He, 2016, Journal of immunology research.

In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells

C. Niu, Ji-fan Hu, Hua He, 2015, BMC Immunology.

Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer

C. Niu, Yizhuo Wang, Huijie Xiao, 2016, Cancer medicine.

BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists

C. Niu, Hui Li, Zheng Hu, 2023, Journal of Translational Medicine.

Sintilimab plus autologous NK cells as second-line treatment for advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy

C. Niu, Yinghui Xu, K. Ma, 2022, Frontiers in Immunology.

Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer

C. Niu, Wei Li, Haofan Jin, 2015, Journal of Translational Medicine.

Lipase member H is a novel secreted protein associated with a poor prognosis for breast cancer patients

C. Niu, Haofan Jin, Yanbo Wang, 2014, Tumor Biology.